Abiotic and biotic transformation of torasemide - Occurrence of degradation products in the aquatic environment
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Water Research
- Vol. 177, 115753
- https://doi.org/10.1016/j.watres.2020.115753
Abstract
No abstract availableKeywords
Funding Information
- German Federal Environmental Foundation
- DFG
This publication has 32 references indexed in Scilit:
- Environmental Implications of Hydroxyl Radicals (•OH)Chemical Reviews, 2015
- Occurrence and removal of frequently prescribed pharmaceuticals and corresponding metabolites in wastewater of a sewage treatment plantScience of The Total Environment, 2015
- A reappraisal of loop diuretic choice in heart failure patientsAmerican Heart Journal, 2015
- Electrochemical degradation of sulfonamides at BDD electrode: Kinetics, reaction pathway and eco-toxicity evaluationJournal of Hazardous Materials, 2014
- Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometryJournal of Chromatography A, 2012
- Basic rules for the interpretation of atmospheric pressure ionization mass spectra of small moleculesJournal of Chromatography A, 2010
- High-performance liquid chromatography–tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolitesAnalytical and Bioanalytical Chemistry, 2008
- Mimicry of phase I drug metabolism – novel methods for metabolite characterization and synthesisRapid Communications in Mass Spectrometry, 2007
- Pharmaceuticals: a threat to drinking water?Trends in Biotechnology, 2005
- Simultaneous Determination of Torasemide and Its Major Metabolite M5 in Human Urine by High-Performance Liquid Chromatography-Electrochemical DetectionJournal of Chromatographic Science, 2001